SyntekaBio, Inc. (KOSDAQ:226330)

SyntekaBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7,462	16,346	12,066	19,668	35,342	13,709
Short-Term Investments	-	-	-	-	-	39,000
Cash & Short-Term Investments	7,462	16,346	12,066	19,668	35,342	52,709
Cash Growth	-26.58%	35.47%	-38.65%	-44.35%	-32.95%	28.27%
Accounts Receivable	752.27	846.46	0.19	0.24	1.07	55.04
Other Receivables	187.13	38.22	-	40.67	132.56	113.44
Receivables	1,539	884.69	0.19	40.91	133.63	168.48
Prepaid Expenses	149.15	65.15	136.53	374.72	351.44	185.38
Other Current Assets	154.84	134.93	362.17	1,896	1,670	5,131
Total Current Assets	9,306	17,430	12,565	21,980	37,497	58,193
Property, Plant & Equipment	28,409	28,738	30,672	30,461	17,475	9,054
Other Intangible Assets	258.17	359.22	450.39	443.85	631.99	432.98
Long-Term Accounts Receivable	-	-	-	0	0	-0
Other Long-Term Assets	6.74	6.74	28.11	31.88	85.2	198.27
Total Assets	37,980	46,535	43,715	52,917	55,689	67,879

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	247.41	868.51	428.33	357.38	249.06	226.04
Short-Term Debt	6,361	7,098	7,280	1,803	10,454	-
Current Portion of Leases	12.43	12.43	21.14	262.66	415.2	198.59
Other Current Liabilities	2,949	4,265	8,571	16,975	11,136	1,464
Total Current Liabilities	9,571	12,244	16,301	19,398	22,254	1,888
Long-Term Debt	-	-	-	-	-	8,152
Long-Term Leases	10.05	15.58	12.39	27.94	251.65	485.11
Pension & Post-Retirement Benefits	2,396	2,429	2,240	2,071	1,570	1,337
Other Long-Term Liabilities	77.09	67.5	218.59	191.29	152.09	28,389
Total Liabilities	12,054	14,756	18,772	21,688	24,228	40,252

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	12,129	12,129	7,629	7,615	6,759	6,750
Additional Paid-In Capital	111,848	111,848	92,583	92,602	80,933	73,428
Retained Earnings	-99,529	-93,833	-76,293	-69,018	-57,452	-53,051
Comprehensive Income & Other	1,477	1,634	1,024	29.3	1,221	500.14
Shareholders' Equity	25,926	31,779	24,943	31,228	31,461	27,627
Total Liabilities & Equity	37,980	46,535	43,715	52,917	55,689	67,879

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6,384	7,126	7,314	2,094	11,121	8,836
Net Cash (Debt)	1,079	9,219	4,752	17,574	24,222	43,873
Net Cash Growth	-	94.01%	-72.96%	-27.45%	-44.79%	9.50%
Net Cash Per Share	53.75	591.78	311.60	1227.54	1792.34	3258.50
Filing Date Shares Outstanding	24.2	24.26	15.26	15.23	13.52	13.5
Total Common Shares Outstanding	24.2	24.26	15.26	15.23	13.52	13.5
Working Capital	-264.77	5,186	-3,736	2,581	15,242	56,305
Book Value Per Share	1071.49	1310.02	1634.71	2050.38	2327.37	2046.46
Tangible Book Value	25,668	31,420	24,493	30,784	30,829	27,194
Tangible Book Value Per Share	1060.82	1295.21	1605.20	2021.24	2280.62	2014.38
Land	4,954	4,954	4,954	4,954	4,936	4,936
Buildings	22,926	22,355	22,355	22,335	-	-
Machinery	9,790	9,771	9,912	7,562	6,144	5,654
Construction In Progress	-	-	-	-	9,212	208

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error